As we approach the fall of 2025, Connecticut residents are facing a significant shift in how one of the state’s most accessible “natural” remedies is regulated. Kratom, a leafy plant native to Southeast Asia, has long been marketed as a herbal supplement for pain relief, energy boosts, and even anxiety management. But beneath its green packaging lies a substance with potent opioid-like effects that can lead to addiction and severe withdrawal. With House Bill 6855 set to reclassify kratom as a controlled substance, effective October 1, 2025, it’s time to unpack its widespread availability, the risks involved, and where those affected can turn for help. 


Kratom’s Easy Access: A Staple at Gas Stations and Beyond
Walk into just about any gas station, convenience store, or smoke shop across Connecticut—from the bustling stops along I-95 in Fairfield County to rural outposts in Litchfield—and you’re likely to spot it. Kratom arrives in colorful pouches of powder, capsules, or even pre-mixed drinks, often labeled as “all-natural” energy aids or pain relievers. Priced affordably at $10–$20 per package, it’s an impulse buy for truck drivers pulling off the highway or locals grabbing a coffee. This ubiquity has made kratom one of the most common unregulated botanicals in the state, with vendors facing little oversight until now.
Proponents tout its traditional use in tea form for mild stimulation, but in the U.S., extracts and concentrates amplify its effects, turning it into what some critics call “gas station heroin.” In Connecticut, where it’s been legally sold without age restrictions in many places, this easy access has fueled a quiet surge in use, particularly among those seeking alternatives to prescription opioids amid the ongoing addiction crisis. 


How Many Are Using It? A Growing National and Local Trend
Nationally, kratom’s reach is substantial. According to recent data, an estimated 1.9 million Americans reported using kratom in the past year as of 2022, with lifetime use hovering around 1.5% of the population. That’s millions potentially exposed to its risks, including a subset—up to 12.3% of regular users—who develop full-blown addiction requiring professional intervention. Poison control centers logged over 3,400 kratom-related calls from 2014 to 2019 alone, highlighting its role in emergencies like seizures and respiratory distress.
In Connecticut, specific statewide figures are harder to pin down, but the plant’s popularity mirrors national patterns. With kratom readily available at thousands of retail points, including hundreds of gas stations, experts estimate thousands of residents—particularly in urban areas like Hartford, New Haven, and Bridgeport—are regular users. Many start innocently: a friend recommends it for chronic back pain or post-workout soreness, unaware that habitual use can rewire the brain’s reward system in weeks. 


The Allure and the Trap: From Natural Remedy to Dependency
Kratom’s active compounds, mitragynine and 7-hydroxymitragynine, bind to opioid receptors in the brain, offering euphoria and analgesia at low doses but sedation and withdrawal at higher ones. Marketed as a “safer” alternative to pharmaceuticals, it’s often the first step for those self-treating conditions like fibromyalgia or opioid withdrawal itself. Yet, this gateway can lead to dependency faster than expected. Users report building tolerance quickly, escalating from a few grams a day to double-digit doses just to feel normal.
Withdrawal hits hard—think flu-like symptoms on steroids: intense muscle aches, insomnia, irritability, and even psychological distress akin to opioid detox. For many in Connecticut, the realization comes too late. “I thought it was just a plant,” one former user shared in local forums. Stories like these underscores how kratom preys on the desperate, turning a quest for relief into a cycle of addiction. 


Connecticut’s Response: House Bill 6855 and the October 1 Ban
Recognizing these dangers, Connecticut lawmakers acted decisively with House Bill 6855, passed in June 2025 as part of broader drug control reforms. The bill empowers the Department of Consumer Protection to schedule kratom (Mitragyna speciosa) as a controlled substance, effectively banning its sale, possession, and distribution starting October 1, 2025. This makes Connecticut the seventh state to take such a step, aligning with federal scrutiny from the FDA, which has long warned against its unproven safety.
Critics, including the American Kratom Association, argue the ban overlooks “safe” leaf forms in favor of targeting synthetics, but supporters emphasize public health: unregulated products often contain contaminants or inconsistent potency. As the deadline looms, retailers are scrambling to clear shelves, but for those already dependent, the real challenge is what’s next. 


Finding Recovery: How Waterstone Can Help 


If you or a loved one is grappling with kratom dependency in Connecticut, you’re not alone—and help is available right here at home. Waterstone, a leader in addiction and mental health recovery, specializes in treating substance use disorders, including emerging ones like kratom. Our evidence-based programs incorporate Medication-Assisted Treatment (MAT), cognitive behavioral therapy, and motivational interviewing to address both the physical cravings and underlying triggers. 


What sets Waterstone apart?  

 

Kratom’s ban is a step toward protection, but recovery starts with a single call. At Waterstone, we’ve helped hundreds reclaim their lives from addiction’s grip.  

Waterstone has locations in New London, Madison and Hamden, Connecticut 

Reach out today at (203) 245-0412 or visit waterstonecenter.com to get more information regarding our services. Waterstone accepts all major health insurance including Medicaid and Medicare. 

The Hidden Dangers of Kratom in Connecticut: From Gas Station Shelves to an Impending Ban 

As we approach the fall of 2025, Connecticut residents are facing a significant shift in how one of the state’s most accessible “natural” remedies is regulated. Kratom, a leafy plant native to Southeast Asia, has long been marketed as a herbal supplement for pain relief, energy boosts, and even anxiety management. But beneath its green packaging lies a substance with potent opioid-like effects that can lead to addiction and severe withdrawal. With House Bill 6855 set to reclassify kratom as a controlled substance, effective October 1, 2025, it’s time to unpack its widespread availability, the risks involved, and where those affected can turn for help. 


Kratom’s Easy Access: A Staple at Gas Stations and Beyond
Walk into just about any gas station, convenience store, or smoke shop across Connecticut—from the bustling stops along I-95 in Fairfield County to rural outposts in Litchfield—and you’re likely to spot it. Kratom arrives in colorful pouches of powder, capsules, or even pre-mixed drinks, often labeled as “all-natural” energy aids or pain relievers. Priced affordably at $10–$20 per package, it’s an impulse buy for truck drivers pulling off the highway or locals grabbing a coffee. This ubiquity has made kratom one of the most common unregulated botanicals in the state, with vendors facing little oversight until now.
Proponents tout its traditional use in tea form for mild stimulation, but in the U.S., extracts and concentrates amplify its effects, turning it into what some critics call “gas station heroin.” In Connecticut, where it’s been legally sold without age restrictions in many places, this easy access has fueled a quiet surge in use, particularly among those seeking alternatives to prescription opioids amid the ongoing addiction crisis. 


How Many Are Using It? A Growing National and Local Trend
Nationally, kratom’s reach is substantial. According to recent data, an estimated 1.9 million Americans reported using kratom in the past year as of 2022, with lifetime use hovering around 1.5% of the population. That’s millions potentially exposed to its risks, including a subset—up to 12.3% of regular users—who develop full-blown addiction requiring professional intervention. Poison control centers logged over 3,400 kratom-related calls from 2014 to 2019 alone, highlighting its role in emergencies like seizures and respiratory distress.
In Connecticut, specific statewide figures are harder to pin down, but the plant’s popularity mirrors national patterns. With kratom readily available at thousands of retail points, including hundreds of gas stations, experts estimate thousands of residents—particularly in urban areas like Hartford, New Haven, and Bridgeport—are regular users. Many start innocently: a friend recommends it for chronic back pain or post-workout soreness, unaware that habitual use can rewire the brain’s reward system in weeks. 


The Allure and the Trap: From Natural Remedy to Dependency
Kratom’s active compounds, mitragynine and 7-hydroxymitragynine, bind to opioid receptors in the brain, offering euphoria and analgesia at low doses but sedation and withdrawal at higher ones. Marketed as a “safer” alternative to pharmaceuticals, it’s often the first step for those self-treating conditions like fibromyalgia or opioid withdrawal itself. Yet, this gateway can lead to dependency faster than expected. Users report building tolerance quickly, escalating from a few grams a day to double-digit doses just to feel normal.
Withdrawal hits hard—think flu-like symptoms on steroids: intense muscle aches, insomnia, irritability, and even psychological distress akin to opioid detox. For many in Connecticut, the realization comes too late. “I thought it was just a plant,” one former user shared in local forums. Stories like these underscores how kratom preys on the desperate, turning a quest for relief into a cycle of addiction. 


Connecticut’s Response: House Bill 6855 and the October 1 Ban
Recognizing these dangers, Connecticut lawmakers acted decisively with House Bill 6855, passed in June 2025 as part of broader drug control reforms. The bill empowers the Department of Consumer Protection to schedule kratom (Mitragyna speciosa) as a controlled substance, effectively banning its sale, possession, and distribution starting October 1, 2025. This makes Connecticut the seventh state to take such a step, aligning with federal scrutiny from the FDA, which has long warned against its unproven safety.
Critics, including the American Kratom Association, argue the ban overlooks “safe” leaf forms in favor of targeting synthetics, but supporters emphasize public health: unregulated products often contain contaminants or inconsistent potency. As the deadline looms, retailers are scrambling to clear shelves, but for those already dependent, the real challenge is what’s next. 


Finding Recovery: How Waterstone Can Help 


If you or a loved one is grappling with kratom dependency in Connecticut, you’re not alone—and help is available right here at home. Waterstone, a leader in addiction and mental health recovery, specializes in treating substance use disorders, including emerging ones like kratom. Our evidence-based programs incorporate Medication-Assisted Treatment (MAT), cognitive behavioral therapy, and motivational interviewing to address both the physical cravings and underlying triggers. 


What sets Waterstone apart?  

 

Kratom’s ban is a step toward protection, but recovery starts with a single call. At Waterstone, we’ve helped hundreds reclaim their lives from addiction’s grip.  

Waterstone has locations in New London, Madison and Hamden, Connecticut 

Reach out today at (203) 245-0412 or visit waterstonecenter.com to get more information regarding our services. Waterstone accepts all major health insurance including Medicaid and Medicare. 

Thank you! We will get back to you as soon as possible.

Request an Appointment